169 related articles for article (PubMed ID: 10980994)
1. Proton pump inhibitors and H. pylori infection: why the concern?
Weinstein WM
Curr Gastroenterol Rep; 1999 Dec; 1(6):507-10. PubMed ID: 10980994
[TBL] [Abstract][Full Text] [Related]
2. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
Ohkusa T; Fujiki K; Takashimizu I; Kumagai J; Tanizawa T; Eishi Y; Yokoyama T; Watanabe M
Ann Intern Med; 2001 Mar; 134(5):380-6. PubMed ID: 11242498
[TBL] [Abstract][Full Text] [Related]
3. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Uemura N; Okamoto S; Yamamoto S; Matsumura N; Yamaguchi S; Mashiba H; Sasaki N; Taniyama K
Aliment Pharmacol Ther; 2000 Oct; 14(10):1345-52. PubMed ID: 11012481
[TBL] [Abstract][Full Text] [Related]
4. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
5. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Kokkola A; Sipponen P; Rautelin H; Härkönen M; Kosunen TU; Haapiainen R; Puolakkainen P
Aliment Pharmacol Ther; 2002 Mar; 16(3):515-20. PubMed ID: 11876705
[TBL] [Abstract][Full Text] [Related]
6. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
Stolte M; Meining A; Schmitz JM; Alexandridis T; Seifert E
Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
[TBL] [Abstract][Full Text] [Related]
7. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
[TBL] [Abstract][Full Text] [Related]
8. Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
Geboes K; Dekker W; Mulder CJ; Nusteling K;
Aliment Pharmacol Ther; 2001 Nov; 15(11):1819-26. PubMed ID: 11683696
[TBL] [Abstract][Full Text] [Related]
9. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
[TBL] [Abstract][Full Text] [Related]
10. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
Marusic M; Babic Z; Nesanovic M; Lucijanic-Mlinac M; Stajcar V
World J Gastroenterol; 2005 Apr; 11(15):2334-6. PubMed ID: 15818748
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
Dattilo M; Figura N
J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
13. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients.
Uemura N; Oomoto Y; Mukai T; Okamoto S; Yamaguchi S; Mashiba H; Taniyama K; Sasaki N; Sumii K; Haruma K; Kajiyama G
Aliment Pharmacol Ther; 1997 Aug; 11(4):793-800. PubMed ID: 9305491
[TBL] [Abstract][Full Text] [Related]
14. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
[TBL] [Abstract][Full Text] [Related]
15. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
[TBL] [Abstract][Full Text] [Related]
16. Problems associated with the clinical use of proton pump inhibitors.
Gillen D; McColl KE
Pharmacol Toxicol; 2001 Dec; 89(6):281-6. PubMed ID: 11903952
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
19. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.
Hazell SL; Mitchell HM; Hanna G; Daskalopoulos G
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):530-2. PubMed ID: 9272389
[TBL] [Abstract][Full Text] [Related]
20. Role of Helicobacter pylori in gastric carcinoma.
Prabhu SR; Amrapurkar AD; Amrapurkar DN
Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]